ACR2022 - Day 1

Save

Frailty in Vasculitis Dr. Patricia Harkins sits down with Professor Sebastian Sattui to discuss Abstract 0444, Prevalence of Frailty and Associated Factors in Patients with Vasculitis, being presented on Saturday at ACR22 Convergence. Lupus, Sex and STDs Dr.

Prelude To A Meeting (ACR22) (11.11.2022)

Save

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com and looks forward to highlight sessions in the next few days at ACR Convergence 2022.

QD Clinics - ACR 2022

Save

QD201 - Seropositive Arthralgia (abstract #1604) https://youtu.be/uQt_IV3FmZc QD202 -1st Line Anakinra (abstract #L12) https://youtu.be/QyDVQBnYqn4 QD203 - When to Worry About Malignancy and Myositis (abstract #002) ht

Women With Rheumatic Disease (11.4.2022)

Save

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. New regulatory decisions about JAK inhibitors and why do women with rheumatic diseases have unfair outcomes?

Dr Nimesh Dayal on the Use of axSpA Endpoints in Clinical Practice

Save

Dr. Nimesh Dayal (Orlando Health-Health Central Hospital, Orlando, FL) discusses the relevance of clinical endpoints and guidelines for ax-SpA in clinical practice. Sponsored by AbbVie Medical Affairs

Infections & Lupus (10.28.2022)

Save

Dr. Jack Cush discussess the news and journal reports from the past week on RheumNow.com . This week more lupus nephritis, more drug induced lupus and more lupus infections that may kill.

ACR Award Winners (10.21.2022)

Save

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Highlighted discussion of implantable stimulators, urine proteomics and gut-immune responses to Prevotella in RA.

AOSD - Adult - Onset Still's Disease

Save

Review of Adult-onset Still's Disease by Dr. Jack Cush, Executive Editor of RheumNow.com

Primer On Clinical Trials (10.14.2022)

Save

Dr. Jack Cush reviews: - Should you do clinical trials? - how to start in clinical trials - Types of studies - Benefits to research

Thats Not My Name (10.7.2022)

Save

Dr. Jack Cush goes off on "Untitling" (not using proper names/titles) in the clinic, in additon to reports on rheumatologist salaries, new drugs in phase 1-3 development and the range of COVID-19 MSK symptoms -- all from the past week on RheumNow.com.

Perspectives on the safety of a JAK inhibitor in RA, PsA, and AS–Sponsored by AbbVie Medical Affairs

Save

Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.

Great And Not - So Great (9.30.2022)

Save

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.